0001140361-23-045819.txt : 20230928 0001140361-23-045819.hdr.sgml : 20230928 20230928213033 ACCESSION NUMBER: 0001140361-23-045819 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230928 DATE AS OF CHANGE: 20230928 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Roivant Sciences Ltd. CENTRAL INDEX KEY: 0001635088 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981173944 STATE OF INCORPORATION: D0 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-40782 FILM NUMBER: 231291563 BUSINESS ADDRESS: STREET 1: CLARENDON HOUSE, 2 CHURCH STREET CITY: HAMILTON HM11 STATE: D0 ZIP: HM11 BUSINESS PHONE: 441-295-5950 MAIL ADDRESS: STREET 1: CLARENDON HOUSE STREET 2: 2 CHURCH STREET CITY: HAMILTON STATE: D0 ZIP: HM11 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Ramaswamy Vivek CENTRAL INDEX KEY: 0001635075 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O ONCORE BIOPHARMA, INC. STREET 2: 3805 OLD EASTON ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18902 FORMER COMPANY: FORMER CONFORMED NAME: Ramasawamy Vivek DATE OF NAME CHANGE: 20150226 144 1 primary_doc.xml 144 0001635075 XXXXXXXX LIVE 0001635088 Roivant Sciences Ltd. 001-40782 7th Floor 50 Broadway London X0 SW1H 0DB 44 207 400 3347 Ramaswamy Vivek 10% Stockholder Common shares, $0.0000000341740141 par value per share (???Common Shares???) E*TRADE FINANCIAL CORPORATION

3 EDISONDRIVE ALPHARETTA GA 30005

61947 817080.93 771742197 09/28/2023 NASDAQ Common Shares 09/27/2023 Capped Value Appreciation Rights granted under the Roivant Sciences Ltd. Amended and Restated 2015 Equity Incentive Plan Roivant Sciences Ltd. N 61947 09/27/2023 N/A N Vivek Ramaswamy

PO Box 20860 Columbus OH 43220

Common Shares 07/31/2023 76023 868942.89 Vivek Ramaswamy

PO Box 20860 Columbus OH 43220

Common Shares 08/28/2023 47692 536535 The securities included in Table I represent a maximum number of shares that may be sold to cover the reporting person's tax obligations when capped value appreciation rights belonging to the reporting person are settled. The securities included in Table II represent shares sold to cover the reporting person's tax obligations when capped value appreciation rights belonging to the reporting person were settled. The securities reported in Tables I and II do not represent discretionary trades by the reporting person, and will be sold, or were sold, as applicable, for the limited purpose of satisfying tax withholding obligations. 09/28/2023 02/23/2022 /s/ Steve Robers as attorney-in-fact for Vivek Ramaswamy